title: Quantification of lipid mediator metabolites in human urine from asthma patients by electrospray ionization mass spectrometry: controlling matrix effects.
abstract: Eicosanoids (e.g., prostaglandins and leukotrienes) are inflammatory signaling molecules that are metabolized and excreted in urine. The quantification of eicosanoid metabolites in human urine has been demonstrated to provide insight into the inflammatory and oxidative stress status of the individual. However, urine is a complex matrix that can exhibit profound matrix effects for quantification via liquid chromatography coupled to mass spectrometry (LC-MS/MS). This phenomenon can lead to impairment and biasing of results, because the sample background is dependent on the fluid intake and water-salt balance. Herein we describe an analytical methodology to address these limitations via the normalization of extracted urine volume by the ratio of absorbance at 300 nm to an optimized reference material. The platform is composed of 4 LC-MS/MS methods that collectively quantify 26 lipid mediators and their metabolites, with on-column limits of detection between 0.55 and 15 fmol. Prior to optimization, internal standards exhibited strong matrix effects with up to 50% loss of signal. Notably, the accuracy of exact deuterated structural analogues was found to vary based upon the number of incorporated deteurium. The platform was used to analyze urine from 16 atopic asthmatics under allergen provocation, showing increases in metabolites of prostaglandin D2, cysteinyl leukotrienes, and isoprostanes following the challenge. This method presents a functional and reproducible approach to addressing urine-specific matrix effects that can be readily formatted for quantifying large numbers of samples.
authors.affiliation: Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden. David.Balgoma@ki.se
authors.forename: David
authors.initials: D
authors.lastname: Balgoma
authors.forename: Johan
authors.initials: J
authors.lastname: Larsson
authors.forename: Joshua
authors.initials: J
authors.lastname: Rokach
authors.forename: John A
authors.initials: JA
authors.lastname: Lawson
authors.forename: Kameran
authors.initials: K
authors.lastname: Daham
authors.forename: Barbro
authors.initials: B
authors.lastname: Dahlén
authors.forename: Sven-Erik
authors.initials: SE
authors.lastname: Dahlén
authors.forename: Craig E
authors.initials: CE
authors.lastname: Wheelock
mesh_terms: D001249:Asthma / Q000652:urine*; D002853:Chromatography, Liquid; D006801:Humans; D057230:Limit of Detection; D008055:Lipids / Q000652:urine*; D015203:Reproducibility of Results; D021241:Spectrometry, Mass, Electrospray Ionization / Q000379:methods*; D053719:Tandem Mass Spectrometry / Q000379:methods*
chemical_list: D008055:Lipids